Search for: "Bayer Laboratories, Inc."
Results 1 - 20
of 161
Sort by Relevance
|
Sort by Date
12 Mar 2024, 12:46 pm
., Inc. v. [read post]
11 Nov 2022, 9:40 am
Cir. 2019); Bayer Healthcare LLC v. [read post]
16 Aug 2022, 8:00 am
Abbott Laboratories, Inc. and AbbVie, Inc., 2022 IL App (1st) 210478 (June 23, 2022). [read post]
27 Oct 2021, 5:15 am
(functional trade dress); Impax Laboratories, Inc. v. [read post]
24 Apr 2020, 6:58 am
Abbott Laboratories has drawn praise for developing a relatively reliable, fast diagnostic test for COVID-19, but (at least as of mid-April 2020) its manufacturing capacity has been unable to keep up with demand. [read post]
24 Jan 2020, 10:24 am
Also tagged in this scheme were Novartis, Dendreon, Onyx, Questcor, and Bayer. [read post]
23 Dec 2019, 3:06 am
Cir. 2017) (citing In re Bayer A.G., 488 F.3d 960, 82 USPQ2d 1828, 1831 (Fed. [read post]
21 Oct 2019, 6:30 am
Bayer Corp., CV 07-01(JLL), 2015 WL 5822595 (D.N.J. [read post]
9 Nov 2017, 9:00 pm
Watson Laboratories, Inc. [read post]
6 May 2017, 10:11 am
"Braintree Laboratories, Inc. [read post]
28 Apr 2017, 9:56 am
& Bayer Pharma AG v. [read post]
30 Dec 2016, 7:38 am
Watson Laboratories Inc., 1-12-cv-01726 (DED December 28, 2016, Order) (Stark, USDJ) [read post]
3 Mar 2016, 5:19 am
Wyeth Laboratories, Inc. [read post]
9 Nov 2015, 4:00 am
The court also considered a ‘terminal disclaimer’ filed by a patentee in Bayer Inc. v. [read post]
19 Oct 2015, 10:25 am
Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and/or YAZ™ or from the use of Ocella™ and/or Gianvi™, generic versions of Yasmin™ and YAZ™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
22 Jun 2015, 2:12 pm
Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and/or yaz™ or from the use of Ocella™ and/or Gianvi™, generic versions of Yasmin™ and yaz™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
12 May 2015, 10:24 am
Supreme Court had left up to future lower courts to develop.[1] Cipro began more than a decade ago, stemming from a 1997 settlement of a patent infringement suit between Bayer AG and Bayer Corporation (the brand name patent holder) and Barr Laboratories, Inc. [read post]
16 Mar 2015, 2:17 pm
Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and / or yaz™ or from the use of Ocella™ and / or Gianvi™, generic versions of Yasmin™ and yaz™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
12 Dec 2014, 9:29 am
Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and / or YAZ™ or from the use of Ocella™ and / or Gianvi™, generic versions of Yasmin™ and YAZ™, respectively, marketed by Barr Laboratories, Inc. in the United States. [read post]
26 Jul 2014, 9:14 pm
Methods of medical treatment came under scrutiny of the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories, Inc and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (see High Court Rules Methods of Medical Treatment Patent-Eligible). [read post]
